Logo
x

Search

Subscribe Now

Glenmark

Glenmark Enters into a Collaboration Agreement with Jiangsu and 3D Medicines to Develop Envafolimab (KN035) for the Treatment of Cancer Indications

Glenmark Enters into a Collaboration Agreement with Jiangsu and 3D Medicines to Develop Envafolimab (KN035) for the Treatment of C...

  • January 29, 2024
PharmaShots Weekly Snapshots (January 01 – January 05, 2023)

PharmaShots Weekly Snapshots (January 01 – January 05, 2023)

  • January 5, 2024
Glenmark Introduces Lirafit (Biosimilar, Liraglutide) for Type 2 Diabetes Mellitus in India

Glenmark Introduces Lirafit (Biosimilar, Liraglutide) for Type 2 Diabetes Mellitus in India

  • January 5, 2024
Glenmark Launches Lobeglitazone (thiazolidinedione lobeglitazone) for Uncontrolled Type 2 Diabetes in India

Glenmark Launches Lobeglitazone (thiazolidinedione lobeglitazone) for Uncontrolled Type 2 Diabetes in India

  • October 6, 2022
Glenmark’s Ryaltris Nasal Spray Receives the US FDA’s Approval for the Treatment of Seasonal Allergic Rhinitis

Glenmark’s Ryaltris Nasal Spray Receives the US FDA’s Approval for the Treatment of Seasonal Allergic Rhinitis

  • January 14, 2022
PharmaShots Weekly Snapshots (October 25 - 29, 2021)

PharmaShots Weekly Snapshots (October 25 - 29, 2021)

  • October 29, 2021
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.